References in periodicals archive ?
Subsequent to the period end date, three batches of Sodium Phenylbutyrate and Azilsartan respectively have been successfully manufactured in October 2017.
7) Amlodipine, chlorthalidone, and azilsartan medoxomil, all of which have long half-lives, are approximately 50% more potent than other antihypertensive agents.
The novel angiotensin II receptor blocker azilsartan medoxomil ameliorates insulin resistance induced by chronic angiotensin II treatment in rat skeletal muscle," Cardiorenal Medicine, vol.
Common ARBs used to manage HTN include azilsartan (Edarbi[R]), candesartan (Atacand[R]), eprosartan (Teveten[R]), irbesartan (Avapro[R]), losartan (Cozaar[R]), olmesartan (Benicar[R]), telmisartan (Micardis[R]), and valsartan (Diovan[R]).
A rise in the prevalence of hypertension, from a population of 181 million to 190 million, combined with the anticipated launches of azilsartan with amlodipine and AHU377 with valsartan, will also contribute.
Because the compound of sartan drugs and diuretic has better effect than other medication compounds, most sartan and hydrochlorothiazide compound preparations are approved by FDA, including the compound preparation of diuretic chlorthalidone and azilsartan.
Azilsartan medoxomil plus chlorthalidone reduces BP more effectively than olmesartan plus HCTZ in stage 2 systolic hypertension [LB-OR-03].
This edition includes new drugs, including Azilsartan Medoxomil, Boceprevir, Clobazam, Ezogabine, Fidaxomicin, Linagliptin, Rilpivirine, Rivaroxaban, Telaprevir, Roflumilast, Ticagrelor, and Vilazodone; updated bisphosphonate, antipsychotic, carbapenem, and proton pump inhibitor group monographs; new combinations such as Emtricitabine/Rilpivirine/Tenofovir; and a revised ophthalmic/otic chapter with additions like glaucoma combinations, mast cell stabilizers, ophthalmic antihistamines, and otic corticosteroids.
Azilsartan (Edarbi; D) is an angiotensin II receptor blocker used for hypertension.
Food and Drug Administration has approved azilsartan medoxomil with chlorthalidone (Edarbyclor, Takeda) for the treatment of hypertension.
M2 EQUITYBITES-August 17, 2017-Hikma expands licensing agreement for Alogliptin, Azilsartan, Dexlansoprozole and Lornoxicam for MENA